BHVN
NYSE
$15.50
Biohaven Ltd (BHVN)
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $22.75 (+46.77%)
Market Cap
$2.24B
Free Cash Flow Yield
-26.56%
Beta (5Y)
1.45
Price Chart
Valuation
Market Cap$2.24B
P/B17.37
Profitability
Total Revenue (TTM)$14M
EBITDA-$644M
EPS-$5.48
Financial Health
Free Cash Flow Yield-26.56%
Growth & Risk
Beta (5Y)1.45
Sharpe Ratio0.42